United Services Automobile Association’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-6,826
Closed -$703K 1870
2019
Q2
$703K Sell
6,826
-338
-5% -$26.3K ﹤0.01% 1457
2019
Q1
$525K Sell
7,164
-58
-0.8% -$3.95K ﹤0.01% 1613
2018
Q4
$306K Buy
7,222
+173
+2% +$6.89K ﹤0.01% 1810
2018
Q3
$332K Buy
7,049
+1,969
+39% +$110K ﹤0.01% 1888
2018
Q2
$250K Buy
+5,080
New +$192K ﹤0.01% 2030

Other funds holding MRTX

United Services Automobile Association's MRTX Position: Q3 2019 in Review

United Services Automobile Association sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q3 2019, closing a stake of 6,826 shares — an estimated $703K sold.

United Services Automobile Association first reported a position in MRTX in Q2 2018 and held it in 5 quarters. The position peaked at $703K in Q2 2019. 177 funds tracked by Wall St. Rank hold MRTX as of Q3 2019.

  • United Services Automobile Association reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
  • United Services Automobile Association sold 6,826 Mirati Therapeutics, Inc. Common Stock shares in Q3 2019, an estimated $703K.
  • United Services Automobile Association first reported a position in Mirati Therapeutics, Inc. Common Stock in Q2 2018 and held it in 5 quarters.
  • United Services Automobile Association's Mirati Therapeutics, Inc. Common Stock position peaked at $703K in Q2 2019.
  • 177 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q3 2019.

Based on United Services Automobile Association's 13F filing for Q3 2019, filed 13 Nov 2019.